Mehl suffered from an aggressive form of gangrene on her toe that required a partial foot amputation. The infection continued to spread and Mehl risked losing not only her entire foot, but most of her leg below the knee. Learn how ActiGraft saved Mehl from losing not only her entire foot, but most of her leg below the knee.
Mhel suffered from a stroke a few years ago, and as a result, her sister quit her job to become Mhel's primary caretaker. While massaging Mhel's legs, she noticed a dark mole on Mhel's left leg. Mhel developed an aggressive form of gangrene that - after unsuccessful treatment - required a partial foot amputation. Even with the amputation, the infection continued to spread and Mhel risked a second amputation - this time, below-the-knee.
To try to save her leg, Dr. Wahab suggested ActiGraft, a new treatment option that uses a patient's own blood to create an autologous blood clot tissue to heal chronic and acute wounds.
With one application over the course of (8-weeks), Mhel's wound was ninety-five percent healed. Throughout the treatment, Mhel saw constant progress in the wound - it started to heal, and she no longer felt any pain.
Prior to ActiGraft, Mhel lost hope. She feared losing her leg if the wound didn't heal, and she feared losing her ability to ever walk again. But now, Mhel has hope - "Next step: I'm trying to go walk again. In the future, maybe I can go anyplace that I do before."
"We're so grateful that Dr. Wahab chose her - that she was chosen to do that kind of procedure." - Mhel's Sister
April O’Donnell-Haertel, a paraplegic woman, suffered with a debilitating non-healing pressure injury on her buttock for six months.Read Full Story →